These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1762106)

  • 21. Male breast cancer incidence among atomic bomb survivors.
    Ron E; Ikeda T; Preston DL; Tokuoka S
    J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging in Hiroshima and Nagasaki atomic bomb survivors. Speculations based upon the age-specific mortality of persons with malignant neoplasms.
    Anderson RE; Key CR; Yamamoto T; Thorslund T
    Am J Pathol; 1974 Apr; 75(1):1-11. PubMed ID: 4825615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30-year follow-up study.
    Morimoto I; Yoshimoto Y; Sato K; Hamilton HB; Kawamoto S; Izumi M; Nagataki S
    J Nucl Med; 1987 Jul; 28(7):1115-22. PubMed ID: 3598702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. E. Cancers other than leukemia.
    Beebe GW; Kato H
    J Radiat Res; 1975 Sep; 16 Suppl():97-107. PubMed ID: 1195207
    [No Abstract]   [Full Text] [Related]  

  • 26. Exposure to ionizing radiation in adulthood and thyroid cancer incidence.
    Richardson DB
    Epidemiology; 2009 Mar; 20(2):181-7. PubMed ID: 19177023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncancer disease incidence in the atomic bomb survivors: 1958-1986.
    Wong FL; Yamada M; Sasaki H; Kodama K; Akiba S; Shimaoka K; Hosoda Y
    Radiat Res; 1993 Sep; 135(3):418-30. PubMed ID: 8378535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyroid cancer].
    Nagayama Y
    Nihon Rinsho; 2012 Mar; 70(3):436-40. PubMed ID: 22514922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid diseases among atomic bomb survivors in Nagasaki.
    Nagataki S; Shibata Y; Inoue S; Yokoyama N; Izumi M; Shimaoka K
    JAMA; 1994 Aug; 272(5):364-70. PubMed ID: 8028167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
    Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
    J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer.
    Nagano J; Mabuchi K; Yoshimoto Y; Hayashi Y; Tsuda N; Land C; Kodama K
    J Epidemiol; 2007 May; 17(3):76-85. PubMed ID: 17545694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognosis of thyroid nodule cases compared with nodule-free controls in atomic bomb survivors.
    Imaizumi M; Usa T; Tominaga T; Akahoshi M; Ashizawa K; Ichimaru S; Nakashima E; Ishii R; Ejima E; Hida A; Soda M; Maeda R; Nagataki S; Eguchi K
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5009-14. PubMed ID: 15941865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors.
    Cologne JB; Tokuoka S; Beebe GW; Fukuhara T; Mabuchi K
    Radiat Res; 1999 Oct; 152(4):364-73. PubMed ID: 10477913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of non-cancer diseases in atomic bomb survivors.
    Kodama K; Fujiwara S; Yamada M; Kasagi F; Shimizu Y; Shigematsu I
    World Health Stat Q; 1996; 49(1):7-16. PubMed ID: 8896251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of cancer among children exposed to atomic bomb radiation in utero: a review.
    Kato H; Yoshimoto Y; Schull WJ
    IARC Sci Publ; 1989; (96):365-74. PubMed ID: 2680953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors.
    Goodman MT; Cologne JB; Moriwaki H; Vaeth M; Mabuchi K
    Prev Med; 1997; 26(1):144-53. PubMed ID: 9010910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of cancer among atomic bomb survivors.
    Shimizu Y; Kato H; Schull WJ
    J Radiat Res; 1991 Dec; 32 Suppl 2():54-63. PubMed ID: 1823367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.